4//SEC Filing
Akinsanya Karen 4
Accession 0001209191-22-008272
CIK 0001490978other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:14 PM ET
Size
5.5 KB
Accession
0001209191-22-008272
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Award
Stock Option (right to buy)
2022-02-09+80,000→ 80,000 totalExercise: $27.76Exp: 2032-02-09→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.
Documents
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797672
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:14 PM ET
- Size
- 5.5 KB